4th Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for SPARK THERAPEUTICS, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the development of gene therapies for rare diseases S. 4204/ H.R. 2666 MVP ACT

LobbyistCovered position, as disclosed
EMILY FELDER —
ALFRED MOTTUR —
DAVID REID —
ADAM STEINMETZ —
GREGORY SUNSTRUM New Chief of Staff , Rep. Debbie Dingell; Deputy Chief of Staff and Leg. Director, Rep. Debbie Dingell ; Leg. Director, Rep. John Dingell; Leg. Assistant, Rep. John Dingell; Staff Assistant/Leg. Correspondent Rep. John Dingell
DEEMA TARAZI —

Bills named: S. 4204 (118th), H.R. 2666 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.